Gabapentin

Jump to: navigation, search

Synonyms / Brand Names: Neurontin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Dosing and Administration

Gabapentin is given orally with or without food. Half-tablets not used within several days of breaking the scored tablet should be discarded.

Postherpetic Neuralgia: a single 300-mg dose on Day 1, 600 mg/day on Day 2 (divided BID), and 900 mg/day on Day 3 (divided TID). The dose can subsequently be titrated up as needed for pain relief to a daily dose of 1800 mg (divided TID).

Epilepsy: For age 12+, 900 to 1800 mg/day in divided dosage, starting at 300mg TID. For ages 3-12, 10–15 mg/kg/day in 3 divided doses, and the effective dose reached by increasing over 3 days. (effective dose for age 5+:25–35 mg/kg/day divided TID; age 3-4: 40 mg/kg/day divided TID)

Dosage in the elderly:Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and dose should be adjusted based on creatinine clearance values in these patients.



FDA Package Insert Resources
Indications, Contraindications, Side Effects, Drug Interactions, etc.

Calculate Creatine Clearance
On line calculator of your patients Cr Cl by a variety of formulas.

Convert pounds to Kilograms
On line calculator of your patients weight in pounds to Kg for dosing estimates.

Publication Resources
Recent articles, WikiDoc State of the Art Review, Textbook Information

Trial Resources
Ongoing Trials, Trial Results

Guidelines & Evidence Based Medicine Resources
US National Guidelines, Cochrane Collaboration, etc.

Media Resources
Slides, Video, Images, MP3, Podcasts, etc.

Patient Resources
Discussion Groups, Handouts, Blogs, News, etc.

International Resources
en Español






FDA Package Insert Resources

Indications

Contraindications

Side Effects

Drug Interactions

Precautions

Overdose

Instructions for Administration

How Supplied

Pharmacokinetics and Molecular Data

FDA label

FDA on Gabapentin

Return to top

Publication Resources

Most Recent Articles on Gabapentin

Review Articles on Gabapentin

Articles on Gabapentin in N Eng J Med, Lancet, BMJ

WikiDoc State of the Art Review

Textbook Information on Gabapentin

Return to top

Trial Resources

Ongoing Trials with Gabapentin at Clinical Trials.gov

Trial Results with Gabapentin

Return to top

Guidelines & Evidence Based Medicine Resources

US National Guidelines Clearinghouse on Gabapentin

Cochrane Collaboration on Gabapentin

Cost Effectiveness of Gabapentin

Return to top

Media Resources

Powerpoint Slides on Gabapentin

Images of Gabapentin

Podcasts & MP3s on Gabapentin

Videos on Gabapentin

Return to top

Patient Resources

Patient Information from National Library of Medicine

Patient Resources on Gabapentin

Discussion Groups on Gabapentin

Patient Handouts on Gabapentin

Blogs on Gabapentin

Gabapentin in the News

Gabapentin in the Marketplace

Return to top

International Resources

Gabapentin en Español

Return to top


The content of this page is taken from the FDA package insert for this drug and should not be edited.


Navigation WikiDoc | WikiPatient | Popular pages | Recently Edited Pages | Recently Added Pictures

Table of Contents In Alphabetical Order | By Individual Diseases | Signs and Symptoms | Physical Examination | Lab Tests | Drugs

Editor Tools Become an Editor | Editors Help Menu | Create a Page | Edit a Page | Upload a Picture or File | Printable version | Permanent link | Maintain Pages | What Pages Link Here
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies
Linked-in.jpg
Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox